SAGE Therapeutics Inc KINETIC Study Topline Results Conference Call Transcript
Good morning. Welcome to Sage Therapeutics conference call to discuss the results of the KINETIC study. (Operator Instructions)
This call is being webcast live on the Investors and Media section of Sage's website at sagerx.com. This call is property of Sage Therapeutics, and recordings, reproduction and transmission of this call without expressed written consent of Sage Therapeutics is strictly prohibited. Please note, this call is being recorded.
I would now like to introduce Jeff Boyle, Vice President, Investor Relations at Sage.
Good morning, and thank you for joining Sage Therapeutics conference call to discuss results from the KINETIC study with SAGE-324 in essential tremor. Before I begin, I encourage everyone to go to the Investors and Media section of our website at sagerx.com, where you can find the press release related to today's call.
I'd like to point out that we will be making forward-looking statements, which are based on our current expectations and beliefs.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |